
GC64340
Zeteletinib
Also known as 2-[6-(6,7-dimethoxyquinolin-3-yl)-3-pyridinyl]-N-[3-(1,1,1-trifluoro-2-methylpropan-2-yl)-1,2-oxazol-5-yl]acetamide
Zeteletinib (BOS-172738; DS-5010) is an orally active, selective RET kinase inhibitor with nanomolar potency against RET and >300-fold selectivity against VEGFR2· Zeteletinib shows exquisite potency for the wild type RET, RETV804M/L gatekeeper mutants, and the most common oncogenic RET mutation M918T· Zeteletinib has potent antitumor activity
ChemicalCAS2216753-97-6MW500.47FormulaC25H23F3N4O4
- CAS number
- 2216753-97-6
- Molecular weight
- 500.47
- Formula
- C25H23F3N4O4
- InChIKey
- KOLQINCWMXQEOF-UHFFFAOYSA-N
- Catalogue number
- GC64340
- Brand
- GLPBIO
Computed properties PubChem CID 134391533 · XLogP 4.6 · TPSA 99.4 Ų · H-bond donors 1
- XLogP
- 4.6
- TPSA
- 99.4 Ų
- H-bond donors
- 1
- H-bond acceptors
- 10
- Rotatable bonds
- 7
- Heavy atoms
- 36
SMILES CC(C)(C1=NOC(=C1)NC(=O)CC2=CN=C(C=C2)C3=CN=C4C=C(C(=CC4=C3)OC)OC)C(F)(F)F
Computed descriptors from PubChem (CID 134391533), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il